173 related articles for article (PubMed ID: 26799188)
1. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
[TBL] [Abstract][Full Text] [Related]
3. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis.
Hu S; Liu J; Feng S; Wang Y; Liu H
Aging (Albany NY); 2021 Apr; 13(9):12479-12492. PubMed ID: 33902004
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
[TBL] [Abstract][Full Text] [Related]
6. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.
Zhou Y; He P; Xie X; Sun C
Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.
Zhang LM; Wang P; Liu XM; Zhang YJ
Am J Transl Res; 2017; 9(12):5461-5472. PubMed ID: 29312498
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
13. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a.
Liu J; Song Z; Feng C; Lu Y; Zhou Y; Lin Y; Dong C
Am J Transl Res; 2017; 9(12):5594-5602. PubMed ID: 29312511
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway.
Tian C; Jin Y; Shi S
Oncol Lett; 2018 Nov; 16(5):6109-6115. PubMed ID: 30333879
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression.
Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R
Front Oncol; 2024; 14():1325157. PubMed ID: 38846969
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein.
Guo Y; Wang Y; Ma Y; Chen G; Yue P; Li Y
RSC Adv; 2020 Feb; 10(10):6006-6016. PubMed ID: 35497433
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]